Lv32
240 积分 2021-11-02 加入
Research progress in OX40/OX40L in allergic diseases
1小时前
已完结
Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs
1小时前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
11天前
已完结
Emerging biological treatments for asthma
12天前
已完结
New Targeted Therapies for Uncontrolled Asthma
12天前
已完结
IL-33/ST2 axis in autoimmune disease
12天前
已完结
Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases
17天前
已完结
Strategies targeting IL-33/ST2 axis in the treatment of allergic diseases
2个月前
已完结
Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo
3个月前
已完结
Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues
3个月前
已关闭
皖公网安备34019202002308
